Done sou Salè H1B

Akèy › Metiyè › Bioengineers and Biomedical Engineers › Irvine, CA

Bioengineers and Biomedical Engineers nan Irvine, CA: Salè H-1B

112 aplikasyon kondisyon travay pou okipasyon sa a ak yon sit travay nan Irvine, CA. Salè baz medyàn ofri $116,694; mwatye mitan $99,506–$133,310.

Demann (LCA)112
Salè medyan ofri$116,694
Mwatye salè yo$99,506–$133,310
10yèm–90yèm pousantaj$77,965–$149,675

Pa nivo salè

Nivo revniSalè medyan
Nivo I (antre)$85,675
Nivo II (kalifye)$99,008
Nivo III (eksperyans)$121,000
Nivo IV (plen kompetans)$136,140

Depatman Travay la etabli kat nivo salè prevanlan pou chak okipasyon ak zòn, soti nan Nivo I (antre) rive nan Nivo IV (plen kompetans). Anplwayè a chwazi nivo ki koresponn ak kondisyon travay la.

Anplwayè yo

AnplwayèLCASalè medyan
Edwards Lifesciences LLC17$120,078
Masimo Corporation17$121,000
Covidien LP12$112,684
Biosense Webster, Inc.9$125,100
University of California, Irvine5$71,632
Enterey, Inc.5$103,660
Diality, Inc.4$148,464
Becton, Dickinson and Company4$137,500
AbbVie Inc.3$133,500
Medtronic, Inc.2$123,782
Fluxergy, Inc.2$89,000
The Fountain Group, LLC2$135,200
Zymo Research Corporation2$95,838
Truabutment, Inc.2$71,906
Eurofins Electrical and Electronic Testing NA, LLC2$135,000
Advanced Sterilization Products, Inc.2$131,435
626Opco, LLC2$209,000
Masimo Americas, Inc.2$138,140
Invoy, LLC1$116,688
Cercacor Laboratories, Inc.1$77,646
CytoChip Inc1$85,000
Vyaire Medical, Inc.1$116,688
MP Biomedicals, LLC1$78,000
Cue Health, Inc.1$107,217
CSA America Testing & Certification, LLC1$120,000
Applied Medical Resources Corporation1$140,000
Tandem Diabetes Care, Inc.1$99,008
Innolcon Research, Inc.1$93,000
Meacor Inc.1$120,000
Magic Leap, Inc.1$225,000
Amplify Surgical, Inc.1$92,290
Populus Group LLC1$108,160
Planet Innovation, Inc.1$110,000
Hoya Surgical Optics, Inc.1$85,675
Medennium Inc1$86,000
Integra LifeSciences Corporation1$152,153

Tit travay

Pwonse H-1B nan Irvine, CA →

Salè yo se fen ki pi ba nan salè yo ofri sou chak aplikasyon, konvèti nan yon montan anyèl; estatistik yo itilize sèlman aplikasyon tan plen sètifye. Yon LCA pa yon apwobasyon visa epi yon sèl LCA ka kouvri plizyè pozisyon. Sous: Depatman Travay Etazini, Done Divulgasyon LCA OFLC, ane fiskal 2023–2026 (dènye desizyon Jun 30, 2026).